Wedgewood Investors’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$219K Hold
1,701
0.22% 103
2026
Q1
$205K Buy
+1,701
New +$196K 0.23% 96
2025
Q1
Sell
-2,086
Closed -$208K 100
2024
Q4
$208K Hold
2,086
0.24% 95
2024
Q3
$237K Hold
2,086
0.26% 91
2024
Q2
$258K Buy
+2,086
New +$269K 0.31% 83
2023
Q4
$227K Hold
2,086
0.28% 89
2023
Q3
$215K Sell
2,086
-200
-9% -$21.6K 0.29% 89
2023
Q2
$264K Hold
2,286
0.34% 79
2023
Q1
$243K Hold
2,286
0.32% 83
2022
Q4
$254K Buy
+2,286
New +$234K 0.33% 79

Other funds holding MRK

Wedgewood Investors's MRK Position: Q2 2026 in Review

Wedgewood Investors held its Merck (MRK) position steady in Q2 2026 at 1,701 shares worth $219K. The position accounts for 0.22% of the portfolio, ranked #103.

Wedgewood Investors first reported a position in MRK in Q4 2022 and has held it in 10 quarters since. The position peaked at $264K in Q2 2023. 1,867 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Wedgewood Investors held 1,701 shares of Merck worth $219K as of Q2 2026.
  • Wedgewood Investors left its Merck share count unchanged in Q2 2026.
  • Merck made up 0.22% of Wedgewood Investors's portfolio in Q2 2026, its #103 holding.
  • Wedgewood Investors first reported a position in Merck in Q4 2022 and has held it in 10 quarters since.
  • Wedgewood Investors's Merck position peaked at $264K in Q2 2023.
  • 1,867 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Wedgewood Investors's 13F filing for Q2 2026, filed 31 Jul 2026.